Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Scientists Discover That Shape Matters… >

Scientists Discover That Shape Matters in DNA Nanoparticle Therapy

Published: October 12, 2012.
Released by Northwestern University  

Researchers from Johns Hopkins and Northwestern universities have discovered how to control the shape of nanoparticles that move DNA through the body and have shown that the shapes of these carriers may make a big difference in how well they work in treating cancer and other diseases.

This study, to be published in the Oct. 12 online edition of the journal Advanced Materials, is also noteworthy because this gene therapy technique does not use a virus to carry DNA into cells. Some gene therapy efforts that rely on viruses have posed health risks.

"These nanoparticles could become a safer and more effective delivery vehicle for gene therapy, targeting genetic diseases, cancer and other illnesses that can be treated with gene medicine," said Hai-Quan Mao, an associate professor of materials science and engineering in Johns Hopkins' Whiting School of Engineering.

Mao, co-corresponding author of the Advanced Materials article, has been developing nonviral nanoparticles for gene therapy for a decade. His approach involves compressing healthy snippets of DNA within protective polymer coatings. The particles are designed to deliver their genetic payload only after they have moved through the bloodstream and entered the target cells. Within the cells, the polymer degrades and releases DNA. Using this DNA as a template, the cells can produce functional proteins that combat disease.

A major advance in this work is that Mao and his colleagues reported that they were able to "tune" these particles in three shapes, resembling rods, worms and spheres, which mimic the shapes and sizes of viral particles. "We could observe these shapes in the lab, but we did not fully understand why they assumed these shapes and how to control the process well," Mao said. These questions were important because the DNA delivery system he envisions may require specific, uniform shapes.

To solve this problem, Mao sought help about three years ago from colleagues at Northwestern. While Mao works in a traditional wet lab, the Northwestern researchers are experts in conducting similar experiments with powerful computer models.

Erik Luijten, associate professor of materials science and engineering and of applied mathematics at Northwestern's McCormick School of Engineering and Applied Science and co-corresponding author of the paper, led the computational analysis of the findings to determine why the nanoparticles formed into different shapes.

"Our computer simulations and theoretical model have provided a mechanistic understanding, identifying what is responsible for this shape change," Luijten said. "We now can predict precisely how to choose the nanoparticle components if one wants to obtain a certain shape."

The use of computer models allowed Luijten's team to mimic traditional lab experiments at a far faster pace. These molecular dynamic simulations were performed on Quest, Northwestern's high-performance computing system. The computations were so complex that some of them required 96 computer processors working simultaneously for one month.

In their paper, the researchers also wanted to show the importance of particle shapes in delivering gene therapy. Team members conducted animal tests, all using the same particle materials and the same DNA. The only difference was in the shape of the particles: rods, worms and spheres.

"The worm-shaped particles resulted in 1,600 times more gene expression in the liver cells than the other shapes," Mao said. "This means that producing nanoparticles in this particular shape could be the more efficient way to deliver gene therapy to these cells."

The particle shapes used in this research are formed by packaging the DNA with polymers and exposing them to various dilutions of an organic solvent. DNA's aversion to the solvent, with the help of the team's designed polymer, causes the nanoparticles to contract into a certain shape with a "shield" around the genetic material to protect it from being cleared by immune cells.




The above story is based on materials provided by Northwestern University.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Nanoparticles 
5/30/13 
New Gene Delivery Method: Magnetic Nanoparticles
Bethesda, MD—Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as …
Vectors 
2/28/13 
Researchers Show That Lipid Nanoparticles Are Ideal for Delivering Genes And Drugs
At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team …
Kumar-Singh 
8/16/10 

Breakthrough Gene Therapy Prevents Retinal Degeneration
Gene 
8/11/10 
Deathstalker Scorpion Venom Could Improve Gene Therapy for Brain Cancer
An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain …
Gene 
7/9/12 
An Economical, Effective And Biocompatible Gene Therapy Strategy Promotes Cardiac Repair
Dr Changfa Guo, Professor Chunsheng Wang and their co-investigators from Zhongshan hospital Fudan University, Shanghai, China have established a …
Gene 
8/10/11 
Genetically Engineered Spider Silk for Gene Therapy
Genetically engineered spider silk could help overcome a major barrier to the use of gene therapy in everyday medicine, …
Therapy 
2/7/13 
UAB Researchers Cure Type 1 Diabetes in Dogs
Researchers from the Universitat Autònoma de Barcelona (UAB), led by FĂ tima Bosch, have shown for the first time that …
Cd59 
4/30/11 
Gene Therapy Shows Promise Against Age-related Macular Degeneration
BOSTON (April 29, 2011) — A gene therapy approach using a protein called CD59, or protectin, shows promise in …
Patients 
9/11/12 
UCLA Stem Cell Researchers Use Gene Therapy to Restore Immune Systems in 'Bubble Babies'
UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with …
Vna 
8/29/14 
Mice Study Shows Efficacy of New Gene Therapy Approach for Toxin Exposures
NORTH GRAFTON, Mass. (August 29, 2014, 2 PM US Eastern Time)—The current method to treat acute toxin poisoning is …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile